Last Posted: Jun 13, 2020
- Key steps for effective breast cancer prevention
KL Britt et al, Nat Rev Cancer, June 11, 2020 - Clinical outcome and toxicity from taxanes in breast cancer patients with BRCA1 and BRCA2 pathogenic germline mutations.
Bayraktar Soley et al. The breast journal 2020 Jun - Contralateral breast cancer and tumor recurrence in BRCA1/2 carriers and non-carriers at a high risk of hereditary breast cancer after bilateral mastectomy.
Allué Cabañuz Marta et al. Cirugia espanola 2020 Jun - Molecular characterization of breast cancer needle core biopsy specimens by the 21-gene Breast Recurrence Score test.
Jakubowski Debbie M et al. Journal of surgical oncology 2020 Jun - Pathogenic Germline Mutations in DNA Repair Genes in Combination With Cancer Treatment Exposures and Risk of Subsequent Neoplasms Among Long-Term Survivors of Childhood Cancer.
Qin Na et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2020 Jun JCO1902760 - FGFR aberrations increase the risk of brain metastases and predict poor prognosis in metastatic breast cancer patients.
Xie Ning et al. Therapeutic advances in medical oncology 2020 121758835920915305 - Breast Cancer Risk Assessment: A Step-Wise Approach for Primary Care Providers on the Front Lines of Shared Decision Making.
McClintock Adelaide H et al. Mayo Clinic proceedings 2020 Jun 95(6) 1268-1275 - FGFR4: A promising therapeutic target for breast cancer and other solid tumors.
Levine Kevin M et al. Pharmacology & therapeutics 2020 May 107590 - Predicting Breast Cancer in Chinese Women Using Machine Learning Techniques: Algorithm Development.
Hou Can et al. JMIR medical informatics 2020 Jun 8(6) e17364 - Women with inherited genetic mutations for breast cancer do not always receive treatment according to guidelines.
Printz Carrie et al. Cancer 2020 Jul 126(13) 2955
No hay comentarios:
Publicar un comentario